nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aim and Scope/ Editorial
|
|
|
2013 |
|
3 |
p. ii- 1 p. |
artikel |
2 |
Aims and Scope/ Editorial
|
|
|
2015 |
|
3 |
p. ii- 1 p. |
artikel |
3 |
Aims and Scope/ Editorial Board
|
|
|
2012 |
|
3 |
p. ii- 1 p. |
artikel |
4 |
A national portfolio of bone oncology trials—The Canadian experience in 2012
|
Kuchuk, I. |
|
2012 |
|
3 |
p. 95-100 6 p. |
artikel |
5 |
A systematic review of dosing frequency with bone-targeted agents for patients with bone metastases from breast cancer
|
Hutton, Brian |
|
2013 |
|
3 |
p. 123-131 9 p. |
artikel |
6 |
Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey
|
Hutton, Brian |
|
2013 |
|
3 |
p. 105-109 5 p. |
artikel |
7 |
Bone targeted treatments in cancer – The story so far
|
Coleman, Robert |
|
2016 |
|
3 |
p. 90-92 3 p. |
artikel |
8 |
Cancer-associated fibroblasts – Not-so-innocent bystanders in metastasis to bone?
|
Prajapati, Priyanka |
|
2016 |
|
3 |
p. 128-131 4 p. |
artikel |
9 |
Content List
|
|
|
2015 |
|
3 |
p. iii- 1 p. |
artikel |
10 |
Content List
|
|
|
2012 |
|
3 |
p. iii- 1 p. |
artikel |
11 |
Content List
|
|
|
2013 |
|
3 |
p. iii- 1 p. |
artikel |
12 |
Copyright Page/ Barcode
|
|
|
2015 |
|
3 |
p. I- 1 p. |
artikel |
13 |
Copyright Page/ Barcode
|
|
|
2013 |
|
3 |
p. I- 1 p. |
artikel |
14 |
Copyright page/ Barcode
|
|
|
2012 |
|
3 |
p. I- 1 p. |
artikel |
15 |
Diagnostic and prognostic validity of serum bone turnover markers in bone metastatic non-small cell lung cancer patients
|
Wang, Zhiyu |
|
2015 |
|
3 |
p. 85-91 7 p. |
artikel |
16 |
Dosing of zoledronic acid with its anti-tumor effects in breast cancer
|
Zhao, Xinmin |
|
2015 |
|
3 |
p. 98-101 4 p. |
artikel |
17 |
Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates—Preliminary data
|
Ripamonti, C.I. |
|
2012 |
|
3 |
p. 81-87 7 p. |
artikel |
18 |
Histomorphometric and microarchitectural analyses using the 2mm bone marrow trephine in metastatic breast cancer patients–preliminary results
|
Fralick, M. |
|
2012 |
|
3 |
p. 69-73 5 p. |
artikel |
19 |
Increased insulin mRNA binding protein-3 expression correlates with vascular enhancement of renal cell carcinoma by intravenous contrast-CT and is associated with bone metastasis
|
Xie, Chao |
|
2015 |
|
3 |
p. 69-76 8 p. |
artikel |
20 |
Osteonecrosis of the jaw during biyearly treatment with zoledronic acid for aromatase inhibitor associated bone loss in early breast cancer: A literature review
|
Kourie, Hampig Raphael |
|
2015 |
|
3 |
p. 77-79 3 p. |
artikel |
21 |
Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
|
Picarda, Gaëlle |
|
2013 |
|
3 |
p. 95-104 10 p. |
artikel |
22 |
Pre-treatment serum lactate dehydrogenase and alkaline phosphatase as predictors of metastases in extremity osteosarcoma
|
Marais, Leonard C. |
|
2015 |
|
3 |
p. 80-84 5 p. |
artikel |
23 |
Primary bone lymphomas—Clinical cases and review of literature
|
Jain, Anshu |
|
2013 |
|
3 |
p. 132-136 5 p. |
artikel |
24 |
Primary mixed malignant tumor of bone in an 18-year-old male: Report of a case with radiologic-pathologic correlation
|
Courtier, Jesse |
|
2012 |
|
3 |
p. 101-105 5 p. |
artikel |
25 |
RANK and RANK ligand expression in primary human osteosarcoma
|
Branstetter, Daniel |
|
2015 |
|
3 |
p. 59-68 10 p. |
artikel |
26 |
RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins (cIAPs) in RANK-positive breast cancer cells
|
Casimiro, S. |
|
2013 |
|
3 |
p. 116-122 7 p. |
artikel |
27 |
RANK/RANKL pathway in cancer: Biological activity beyond bone?
|
Pantano, Francesco |
|
2012 |
|
3 |
p. 67-68 2 p. |
artikel |
28 |
Regulation of VEGF by mevalonate pathway inhibition in breast cancer
|
Rachner, Tilman D. |
|
2013 |
|
3 |
p. 110-115 6 p. |
artikel |
29 |
Reproductive hormones in breast cancer bone metastasis: The role of inhibins
|
Wilson, Caroline |
|
2016 |
|
3 |
p. 139-142 4 p. |
artikel |
30 |
Role of sympathetic nerves in the establishment of metastatic breast cancer cells in bone
|
Elefteriou, Florent |
|
2016 |
|
3 |
p. 132-134 3 p. |
artikel |
31 |
Skeletal morbidity rates over time in patients with bone metastases from solid tumors reported in bone modifying agents randomised trials
|
Poon, Michael |
|
2012 |
|
3 |
p. 74-80 7 p. |
artikel |
32 |
The bone microenvironment - Multiple players involved in cancer progression
|
Holen, Ingunn |
|
2016 |
|
3 |
p. 87-89 3 p. |
artikel |
33 |
The Microenvironment Issue JBO Editors introduction
|
|
|
2016 |
|
3 |
p. v- 1 p. |
artikel |
34 |
The role of bone marrow adipocytes in bone metastasis
|
Morris, Emma V. |
|
2016 |
|
3 |
p. 121-123 3 p. |
artikel |
35 |
The role of extracellular calcium in bone metastasis
|
Breuksch, Ines |
|
2016 |
|
3 |
p. 143-145 3 p. |
artikel |
36 |
The role of 18F–NaF PET/CT in metastatic bone disease
|
Araz, Mine |
|
2015 |
|
3 |
p. 92-97 6 p. |
artikel |
37 |
The role of hematopoietic stem cell niche in prostate cancer bone metastasis
|
Decker, A.M. |
|
2016 |
|
3 |
p. 117-120 4 p. |
artikel |
38 |
The role of lysyl oxidase, the extracellular matrix and the pre-metastatic niche in bone metastasis
|
Gartland, Alison |
|
2016 |
|
3 |
p. 100-103 4 p. |
artikel |
39 |
The role of microRNAs in bone metastasis
|
Zoni, Eugenio |
|
2016 |
|
3 |
p. 104-108 5 p. |
artikel |
40 |
The role of osteoblasts in bone metastasis
|
Ottewell, Penelope D |
|
2016 |
|
3 |
p. 124-127 4 p. |
artikel |
41 |
The role of osteoclasts in breast cancer bone metastasis
|
Le Pape, François |
|
2016 |
|
3 |
p. 93-95 3 p. |
artikel |
42 |
The role of platelets and megakaryocytes in bone metastasis
|
Leblanc, Raphael |
|
2016 |
|
3 |
p. 109-111 3 p. |
artikel |
43 |
The role of tumour-associated macrophages in bone metastasis
|
Sousa, Sofia |
|
2016 |
|
3 |
p. 135-138 4 p. |
artikel |
44 |
The unresolved role of systemic factors in bone metastasis
|
Ubellacker, Jessalyn M. |
|
2016 |
|
3 |
p. 96-99 4 p. |
artikel |
45 |
The ZOTECT study: Effect of zoledronic acid on bone metabolism in patients with bone metastases from prostate or breast cancer
|
Hadji, Peyman |
|
2012 |
|
3 |
p. 88-94 7 p. |
artikel |
46 |
Title page
|
|
|
2015 |
|
3 |
p. i- 1 p. |
artikel |
47 |
Title page
|
|
|
2013 |
|
3 |
p. i- 1 p. |
artikel |
48 |
Title page
|
|
|
2012 |
|
3 |
p. i- 1 p. |
artikel |
49 |
Vascular niches for disseminated tumour cells in bone
|
Kusumbe, Anjali P. |
|
2016 |
|
3 |
p. 112-116 5 p. |
artikel |